Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades. - Jamal F; Sahvan O; Junior PLSU; Jones JC; Ou FS; Bekaii-Saab T; Sonbol MB (The oncologist, 2025)